Making Strides Against a Rare Disease: Renal Medullary Carcinoma in Focus

W. Kimryn Rathmell, MD, PhD
Published: Thursday, Jun 08, 2017
Vanderbilt Cancer CenterW. Kimryn Rathmell, MD, PhD
W. Kimryn Rathmell, MD, PhD
Director, Division of Hematology and Oncology
Cornelius A. Craig Professor of Medicine
Professor, Medicine, Cancer Biology, and Biochemistry
Vanderbilt-Ingram Cancer Center Nashville, TN
Strategic Partnership
Renal medullary carcinoma (RMC) is a rare but devastating tumor type almost exclusively affecting young adults carrying 1 copy of hemoglobin beta (HBB) harboring the A17T mutation (HbS). The pathophysiology of the association to HbS, or sickle cell trait, remains unknown. This is a highly aggressive neoplasm, for which there are no established guidelines to direct standards of care.1
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Clinical Practice Connections™: New York Advanced Practice CollaborativeNov 15, 20191.25
Publication Bottom Border
Border Publication